摘要
新型冠状病毒感染(COVID-19)疫情当前已得到有效控制,然而其相关并发症仍不容忽视,尤其是心血管循环系统更是新型冠状病毒(SARS-CoV-2)活跃的场所。血管紧张素转换酶2(ACE2)是一种高表达于心脏、肾脏和睾丸的Ⅰ型跨膜糖蛋白,新型冠状病毒刺突蛋白通过结合细胞表面受体ACE2入侵宿主细胞,但以此为靶点研发的疫苗、药物在临床应用中仍存在诸多不足。亲环素A(CypA)作为分子伴侣可促进蛋白质折叠及T细胞活化,CD147是研究最为广泛的CypA受体之一,CypA/CD147相互作用在新型冠状病毒进入宿主细胞时发挥重要作用,但新型冠状病毒通过CypA/CD147信号通路入侵心血管系统的研究鲜有报道。基于此,本文在总结前期研究证据并结合课题组研究的基础上,通过对CypA/CD147结构功能、CypA/CD147在心血管疾病中的作用及新型冠状病毒靶向CypA/CD147信号通路引发的心血管疾病进行综述,以期为COVID-19感染并发心血管系统疾病的诊疗提供参考。
Corona virus disease 2019(COVID-19)epidemic has been effectively controlled,but its related complications still cannot be ignored,especially the cardiovascular circulatory system is the active site of the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2).Angiotensin-converting enzyme 2(ACE2)is a typeⅠtransmembrane glycoprotein that is highly expressed in heart,kidney and testis.Spike protein of SARS-CoV-2 invades host cells by binding to the cell surface receptor ACE2.However,there are still many deficiencies in the clinical application of vaccines and drugs developed based on this target.As a molecular chaperone,cyclophilin A(CypA)promotes protein folding and T cell activation.CD147 is one of the most widely studied CypA receptors,and the interaction of CypA/CD147 plays an important role in the entry of SARS-CoV-2 into host cells.However,there are few reports on the invasion of SARS-CoV-2 into the cardiovascular system through the CypA/CD147 signaling pathway.Based on this,this article summarizes the previous research evidence and the research basis of the research group,and reviews the structure and function of CypA/CD147,the role of CypA/CD147 in cardiovascular disease,and the cardiovascular disease caused by SARS-CoV-2 targeting CypA/CD147 signal pathway,in order to provide reference for the diagnosis and treatment of the COVID-19 complicated with cardiovascular system diseases.
作者
马明仁
王菲
蔡晓庆
刘燕
马凌
Ma Ming-Ren;Wang Fei;Cai Xiao-Qing;Liu Yan;Ma Ling(Department of Cardiology,the 940th Hospital of Joint Logistics Support Force of Chinese PLA,Lanzhou,Gansu 730050,China)
出处
《解放军医学杂志》
CAS
CSCD
北大核心
2024年第1期115-120,共6页
Medical Journal of Chinese People's Liberation Army
基金
甘肃省自然科学基金(21JR1RA181,GSWSKY2020-01)
解放军联勤保障部队第940医院院内项目(2021yxky080,2021yxky072,2021yxky031)。
关键词
亲环素A
细胞外金属蛋白酶诱导剂
新型冠状病毒
心血管系统
心血管疾病
cyclophilin A
extracellular matrix metalloproteinase inducer
severe acute respiratory syndrome coronavirus 2
cardiovascular system
cardiovascular diseases
